col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

967 Results       Page 1

Elsevier: The Lancet
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―22 Characterising adults in Scotland who are not vaccinated against COVID-19 Safraj Shahul Hameed, Elliott Hall, Zoe Grange, Christopher Sullivan, Sharon Kennedy, Lewis D Ritchie, et al. (+8)
2 [GO] 2022―Sep―14 The Lancet Commission on lessons for the future from the COVID-19 pandemic Jeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Francesca Colombo, et al. (+34)
3 [GO] 2022―Sep―14 COVID-19: the case for prosociality The Lancet
4 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants Christina Yek, Sarah Warner, Alex Mancera, Sameer S Kadri
5 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply Tommy Nyberg, Neil M Ferguson, Joshua Blake, Wes Hinsley, Samir Bhatt, Daniela De Angelis, et al. (+2)
6 [GO] 2022―Sep―01 Protecting older people: a high priority during the COVID-19 pandemic Yifei Zhang, Yufan Wang, Guang Ning, Ping He, Weiqing Wang
7 [GO] 2022―Sep―01 New centre for pandemic therapeutics Jacqui Thornton
8 [GO] 2022―Aug―26 Trust made the difference for democracies in COVID-19 Thomas J Bollyky, Olivia Angelino, Simon Wigley, Joseph L Dieleman
9 [GO] 2022―Aug―26 Forgetting pandemics may be hazardous to your health Howard Markel
10 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa Wim Van Damme, Richard Wamai, Yibeltal Assefa, Laurens Liesenborghs, Dieudonné Mumba
11 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply Reed J D Sorensen
12 [GO] 2022―Aug―04 Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study Aranka V Ballering, Sander K R van Zon, Tim C olde Hartman, Judith G M Rosmalen
13 [GO] 2022―Aug―04 Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Christopher E Brightling, Rachael A Evans
14 [GO] 2022―Aug―04 Global pandemic perspectives: public health, mental health, and lessons for the future Matshidiso Moeti, George F Gao, Helen Herrman
15 [GO] 2022―Jul―28 Violence against health workers rises during COVID-19 Jacqui Thornton
16 [GO] 2022―Jul―28 Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, et al. (+7936)
17 [GO] 2022―Jul―28 Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality Puja Mehta, Boghuma K Titanji
18 [GO] 2022―Jul―18 The UK COVID-19 Inquiry must examine the foundations of pandemic decision making Tom Lawton, Nisreen A Alwan
19 [GO] 2022―Jul―14 Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption Kevin Messacar, Rachel E Baker, Sang Woo Park, Hai Nguyen-Tran, Jessica R Cataldi, Bryan Grenfell
20 [GO] 2022―Jul―11 Perilous two-tier COVID-19 global vaccine roll-out David N Durrheim
21 [GO] 2022―Jul―08 Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA Michelle M Mello, Douglas J Opel, Regina M Benjamin, Timothy Callaghan, Renee DiResta, Jad A Elharake, et al. (+14)
22 [GO] 2022―Jul―06 Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa Ameena Goga, Linda-Gail Bekker, Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Lara Fairall, et al. (+7)
23 [GO] 2022―Jul―01 Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022 Chiara Sacco, Martina Del Manso, Alberto Mateo-Urdiales, Maria Cristina Rota, Daniele Petrone, Flavia Riccardo, et al. (+11)
24 [GO] 2022―Jul―01 COVID-19 vaccination for children aged 5-11 years Shamez N Ladhani
25 [GO] 2022―Jul―01 Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond Tiffany Nassiri-Ansari, Phionah Atuhebwe, Akosua Sika Ayisi, Sarah Goulding, Mira Johri, Pascale Allotey, Nina Schwalbe
26 [GO] 2022―Jul―01 Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2 Florian Pfaff, Donata Hoffmann, Martin Beer
27 [GO] 2022―Jun―29 A new paradigm is needed for financing the pandemic fund Simon Reid-Henry, Jon Lidén, Christoph Benn, Diah Saminarsih, Olivia Herlinda, María Fernanda Bustos Venegas
28 [GO] 2022―Jun―23 COVID-19 in North Korea Talha Burki
29 [GO] 2022―Jun―16 Memorialising COVID-19 Danielle Ofri
30 [GO] 2022―Jun―16 Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 Michela Antonelli, Joan Capdevila Pujol, Tim D Spector, Sebastien Ourselin, Claire J Steves
31 [GO] 2022―Jun―10 COVID-19 mRNA vaccination and myocarditis or pericarditis Anders Husby, Lars Køber
32 [GO] 2022―Jun―10 Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases Hui-Lee Wong, Mao Hu, Cindy Ke Zhou, Patricia C Lloyd, Kandace L Amend, Daniel C Beachler, et al. (+18)
33 [GO] 2022―Jun―10 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial Grace Li, Federica Cappuccini, Natalie G Marchevsky, Parvinder K Aley, Robert Aley, Rachel Anslow, et al. (+65)
34 [GO] 2022―Jun―10 Increasing children's global access to COVID-19 vaccines Manish Patel, Minal Patel
35 [GO] 2022―May―30 Pandemic preparedness means policy makers need to work with social scientists Martyn Pickersgill, Lucinda Manda-Taylor, Natalia Niño-Machado
36 [GO] 2022―May―25 COVID-19 boosters and building trust among UK minority ethnic communities Laura B Nellums, Asam Latif, Kennedy Nkhoma, Stephen Timmons, Manish Pareek, Salma Almidani, Basharat Hussain
37 [GO] 2022―May―19 Where is the next SARS-CoV-2 variant of concern? John J Dennehy, Ravindra K Gupta, William P Hanage, Marc C Johnson, Thomas P Peacock
38 [GO] 2022―May―19 Offline: How to fix pandemic preparedness Richard Horton
39 [GO] 2022―May―18 Transforming or tinkering: the world remains unprepared for the next pandemic threat Helen Clark, Mauricio Cardenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, David Miliband, et al. (+10)
40 [GO] 2022―May―12 Raj Panjabi: bringing a global outlook to the US pandemic response Susan Jaffe
41 [GO] 2022―May―06 Counting the global COVID-19 dead Prabhat Jha, Patrick E Brown, Rashid Ansumana
42 [GO] 2022―May―06 Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic Xinxin Zhang, Wenhong Zhang, Saijuan Chen
43 [GO] 2022―May―05 COVID-19 and inter-generational solidarity Peter Lloyd Sherlock
44 [GO] 2022―May―05 COVID-19: the next phase and beyond The Lancet
45 [GO] 2022―May―05 A global view of the pandemic: the good, bad, and ugly Philip Ball
46 [GO] 2022―May―02 Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
47 [GO] 2022―Apr―28 Africa CDC warns COVID-19 vaccine production could cease Paul Adepoju
48 [GO] 2022―Apr―28 Finding hope in two pandemics Ofole Mgbako
49 [GO] 2022―Apr―25 Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19 David Archard, Alena Buyx, Jean-François Delfraissy
50 [GO] 2022―Apr―21 Transforming the UK's diagnostics agenda after COVID-19 Dimitris K Grammatopoulos, Lawrence Young, Neil R Anderson
51 [GO] 2022―Apr―14 Cracks in the foundation: how COVID-19 showed our failures Mary T Bassett
52 [GO] 2022―Apr―14 Advancing accurate metrics for future pandemic preparedness Francine Ntoumi, Alimuddin Zumla
53 [GO] 2022―Apr―11 What comes next in the COVID-19 pandemic? Dale Fisher, Sameera Suri, Gail Carson
54 [GO] 2022―Apr―08 How to interpret the total number of SARS-CoV-2 infections Kayoko Shioda, Ben Lopman
55 [GO] 2022―Apr―08 Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis Ryan M Barber, Reed J D Sorensen, David M Pigott, Catherine Bisignano, Austin Carter, Joanne O Amlag, et al. (+66)
56 [GO] 2022―Apr―07 SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment Xiaoxu Han, Jinming Li, Yu Chen, Yan Li, Yingchun Xu, Binwu Ying, Hong Shang
57 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition Denis Y Logunov, David M Livermore, David A Ornelles, Wibke Bayer, Ernesto Marques, Cecil Czerkinsky, et al. (+2)
58 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition - Authors’ reply Susan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, Lawrence Corey
59 [GO] 2022―Apr―07 Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study Cristina Menni, Ana M Valdes, Lorenzo Polidori, Michela Antonelli, Satya Penamakuri, Ana Nogal, et al. (+18)
60 [GO] 2022―Mar―31 DNA vaccines join the fight against COVID-19 Anna K Blakney, Linda-Gail Bekker
61 [GO] 2022―Mar―31 Mixed response to COVID-19 intellectual property waiver John Zarocostas
62 [GO] 2022―Mar―31 Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, et al. (+9)
63 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? Douglas F Nixon, Robert E Schwartz, Lishomwa C Ndhlovu
64 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply Philip R Krause, Helen Rees, J Peter Figueroa, Soumya Swaminathan, Ana Maria Henao Restrepo
65 [GO] 2022―Mar―25 Strengthening public mental health during and after the acute phase of the COVID-19 pandemic Lola Kola, Manasi Kumar, Brandon A Kohrt, Tobi Fatodun, Bisola A Olayemi, Adeyinka O Adefolarin
66 [GO] 2022―Mar―25 SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses Maaike C Swets, Clark D Russell, Ewen M Harrison, Annemarie B Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
67 [GO] 2022―Mar―25 Host-targeting oral antiviral drugs to prevent pandemics Raymond A Dwek, John I Bell, Marc Feldmann, Nicole Zitzmann
68 [GO] 2022―Mar―22 Ritonavir and COVID-19: pragmatic guidance is important Laura Waters, Fiona Marra, Anton Pozniak, James Cockburn, Marta Boffito
69 [GO] 2022―Mar―16 Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study Tommy Nyberg, Neil M Ferguson, Sophie G Nash, Harriet H Webster, Seth Flaxman, Nick Andrews, et al. (+46)
70 [GO] 2022―Mar―15 Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study Analía Rearte, Juan Manuel Castelli, Ramiro Rearte, Nora Fuentes, Velen Pennini, Martina Pesce, et al. (+11)
71 [GO] 2022―Mar―15 Evaluating COVID-19 vaccines in the real world Edward J Mills, Gilmar Reis
72 [GO] 2022―Mar―10 Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 Haidong Wang, Katherine R Paulson, Spencer A Pease, Stefanie Watson, Haley Comfort, Peng Zheng, et al. (+90)
73 [GO] 2022―Mar―10 Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study Hui-Ling Yen, Thomas H C Sit, Christopher J Brackman, Shirley S Y Chuk, Haogao Gu, Karina W S Tam, et al. (+19)
74 [GO] 2022―Mar―10 Spreading of SARS-CoV-2 from hamsters to humans Bart L Haagmans, Marion P G Koopmans
75 [GO] 2022―Mar―03 Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021 Luisa S Flor, Joseph Friedman, Cory N Spencer, John Cagney, Alejandra Arrieta, Molly E Herbert, et al. (+16)
76 [GO] 2022―Mar―03 Brazil's COVID-19 guidelines: political hijack of public health Luis C L Correia, Cristina Sette, Marisa Santos, Carlos A S Magliano, Fotini S Toscas
77 [GO] 2022―Mar―02 Gender equality and COVID-19: act now before it is too late Rosemary Morgan, Denise Nacif Pimenta, Sabina Rashid
78 [GO] 2022―Mar―02 Travel measures in the SARS-CoV-2 variant era need clear objectives Adam J Kucharski, Mark Jit, James G Logan, Matthew Cotten, Samuel Clifford, Billy J Quilty, et al. (+4)
79 [GO] 2022―Feb―24 Understanding of COVID-19 from infection-fatality ratio Xiaoying Gu, Bin Cao
80 [GO] 2022―Feb―24 Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
81 [GO] 2022―Feb―24 The global COVID-19 treatment divide Ann Danaiya Usher
82 [GO] 2022―Feb―24 Waning effectiveness of COVID-19 vaccines Hiam Chemaitelly, Laith J Abu-Raddad
83 [GO] 2022―Feb―23 Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression Daniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, Nick Andrews, Rafael Araos, Yair Goldberg, et al. (+8)
84 [GO] 2022―Feb―23 Waning of COVID-19 vaccine effectiveness: individual and public health risk Vanessa Piechotta, Thomas Harder
85 [GO] 2022―Feb―18 Decoupling of omicron variant infections and severe COVID-19 Shabir A Madhi, Chikwe Ihekweazu, Helen Rees, Andrew J Pollard
86 [GO] 2022―Feb―18 COVID-19 booster doses in pregnancy and global vaccine equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Paul Heath, Asma Khalil
87 [GO] 2022―Feb―16 Children, intersectionality, and COVID-19 Katy Dineen, Bengt Autzen, Nisreen A Alwan
88 [GO] 2022―Feb―10 Offline: Complacency threatens progress against COVID-19 Richard Horton
89 [GO] 2022―Feb―10 The vaccinated propor-tion of people with COVID-19 needs context Sam Egger, Garry Egger
90 [GO] 2022―Feb―10 Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6297)
91 [GO] 2022―Feb―10 Another piece in the COVID-19 treatment puzzle Cristina Mussini, Alessandro Cozzi-Lepri
92 [GO] 2022―Feb―05 Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden Peter Nordström, Marcel Ballin, Anna Nordström
93 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 - Authors' reply Damian F Santomauro, Harvey A Whiteford, Alize J Ferrari
94 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 Michael Daly, Eric Robinson
95 [GO] 2022―Feb―03 COVID-19 in Europe: new challenges for addressing vaccine hesitancy Emilie Karafillakis, Pierre Van Damme, Greet Hendrickx, Heidi J Larson
96 [GO] 2022―Feb―03 WHO concerned over COVID-19 health-care waste John Zarocostas
97 [GO] 2022―Feb―03 Ayoade Alakija: advancing equity in the COVID-19 response Udani Samarasekera
98 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air Alison Lopez, Jocelyn Srigley
99 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air - Authors' reply Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufeki, David Fisman, Robert Schooley
100 [GO] 2022―Feb―03 Xenophobia, prejudice, and blame in pandemic times Alexandre I R White
101 [GO] 2022―Feb―02 Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 Thomas J Bollyky, Erin N Hulland, Ryan M Barber, James K Collins, Samantha Kiernan, Mark Moses, et al. (+79)
102 [GO] 2022―Jan―28 Polish Government COVID-19 advisors resign Ed Holt
103 [GO] 2022―Jan―28 High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 Cynthia So-Osman, Sarah J Valk
104 [GO] 2022―Jan―28 Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, et al. (+82)
105 [GO] 2022―Jan―28 Offline: Sex and power during a pandemic Richard Horton
106 [GO] 2022―Jan―28 Urgent care: disability, pandemic, and the value of a life Rachel Adams
107 [GO] 2022―Jan―25 Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Andreas M Schmitt, et al. (+55)
108 [GO] 2022―Jan―21 Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study Sue Ann Costa Clemens, Lily Weckx, Ralf Clemens, Ana Verena Almeida Mendes, Alessandra Ramos Souza, Mariana B V Silveira, et al. (+40)
109 [GO] 2022―Jan―20 Recognising Italy's mistakes in the public health response to COVID-19 Chiara Alfieri, Marc Egrot, Alice Desclaux, Kelley Sams
110 [GO] 2022―Jan―20 Offline: COVID-19 as culture war Richard Horton
111 [GO] 2022―Jan―20 The COVID-19 response in Hong Kong Tong B Tang
112 [GO] 2022―Jan―20 Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Roseanne E Billany, Emma C Wall, Gavin Kelly, et al. (+11)
113 [GO] 2022―Jan―20 Trimeric S protein COVID-19 vaccine needs to find its place Timo Vesikari
114 [GO] 2022―Jan―20 Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study Nicole Wolter, Waasila Jassat, Sibongile Walaza, Richard Welch, Harry Moultrie, Michelle Groome, et al. (+22)
115 [GO] 2022―Jan―20 The overlooked pandemic of antimicrobial resistance Ramanan Laxminarayan
116 [GO] 2022―Jan―20 COVID-19 will continue but the end of the pandemic is near Christopher J L Murray
117 [GO] 2022―Jan―20 Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank Rockhold, et al. (+41)
118 [GO] 2022―Jan―18 Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai Maponga, Wendy A Burgers, Roanne Keeton, et al. (+5)
119 [GO] 2022―Jan―13 Disrupted care in Papua New Guinea: the harms of COVID-19 Chris McCall
120 [GO] 2022―Jan―13 Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin Rajalakshmi Valaiyapathi, Meng-San Wu, Alastair McGregor
121 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right - Authors' reply Ryan P Barbaro, Graeme MacLaren, Justyna Swol, Arthur S Slutsky, Daniel Brodie
122 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right Xosé L Pérez-Fernández, Joan Sabater-Riera, MariPaz Fuset-Cabanes
123 [GO] 2021―Dec―31 Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management Joseph Heskin, Scott J C Pallett, Nabeela Mughal, Gary W Davies, Luke S P Moore, Michael Rayment, Rachael Jones
124 [GO] 2021―Dec―24 Mandatory COVID-19 vaccination and human rights Jeff King, Octávio Luiz Motta Ferraz, Andrew Jones
125 [GO] 2021―Dec―24 Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, et al. (+42)
126 [GO] 2021―Dec―24 Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine Richard B Kennedy
127 [GO] 2021―Dec―22 LGBTQ youth mental health during COVID-19: unmet needs in public health and policy Cameron K Ormiston, Faustine Williams
128 [GO] 2021―Dec―20 Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil Srinivasa Vittal Katikireddi, Thiago Cerqueira-Silva, Eleftheria Vasileiou, Chris Robertson, Sarah Amele, Jiafeng Pan, et al. (+18)
129 [GO] 2021―Dec―20 Diagnostics for COVID-19: moving from pandemic response to control Rosanna W Peeling, David L Heymann, Yik-Ying Teo, Patricia J Garcia
130 [GO] 2021―Dec―20 Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella SV Stuart, Andrew J Pollard, et al. (+8)
131 [GO] 2021―Dec―20 Managing waning vaccine protection against SARS-CoV-2 variants Kathy Leung, Joseph T Wu
132 [GO] 2021―Dec―16 Projecting COVID-19 disruption to elective surgery COVIDSurg Collaborative
133 [GO] 2021―Dec―16 COVID-19 vaccine strategies must focus on severe disease and global equity Peter B McIntyre, Rakesh Aggarwal, Ilesh Jani, Jaleela Jawad, Sonali Kochhar, Noni MacDonald, et al. (+9)
134 [GO] 2021―Dec―16 COVID-19: where do we go from here? The Lancet
135 [GO] 2021―Dec―15 Anticoagulation in COVID-19 Charlotte A Bradbury, Zoe McQuilten
136 [GO] 2021―Dec―15 Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C Spyropoulos, Caroline Candida Carvalho de Oliveira, et al. (+38)
137 [GO] 2021―Dec―11 Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability Suerie Moon, Jana Armstrong, Brian Hutler, Ross Upshur, Rachel Katz, Caesar Atuire, et al. (+12)
138 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Brian Lipworth, Rory Chan, Rasads Misirovs
139 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Ivan Berezowski, Jigar Patel, Mariame Shaw, Ali Pourmand
140 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 - Authors' reply F D Richard Hobbs, Ly-Mee Yu, Benjamin R Saville, Mona Bafadhel, Christopher C Butler
141 [GO] 2021―Dec―08 Preparing for future pandemics in the Eastern Mediterranean region Wasiq Khan, Abdinasir Abubakar, Richard J Brennan, Farida Al Hosani, Thoraya Obaid, Anders Nordstrom, Peter Friberg
142 [GO] 2021―Dec―06 Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 Christopher D Richardson
143 [GO] 2021―Dec―06 Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+37)
144 [GO] 2021―Dec―03 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Salim S Abdool Karim, Quarraisha Abdool Karim
145 [GO] 2021―Dec―02 Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Alasdair P S Munro, Leila Janani, Victoria Cornelius, Parvinder K Aley, Gavin Babbage, David Baxter, et al. (+301)
146 [GO] 2021―Nov―26 Evaluation of the impact of tiered restrictions introduced in England during October and December, 2020, on COVID-19 cases: a synthetic control study Xingna Zhang, Gwilym Owen, Mark Green, Iain Buchan, Ben Barr
147 [GO] 2021―Nov―26 COVID-19 and prepandemic all-cause inequalities in disability-adjusted life-years due to multiple deprivation: a Scottish Burden of Disease study Grant M A Wyper, Eilidh Fletcher, Ian Grant, Oliver Harding, Maria Teresa de Haro Moro, Diane L Stockton, Gerry McCartney
148 [GO] 2021―Nov―26 “It's been up and down”-perspectives on living through COVID-19 for individuals who experience homelessness: a qualitative study Emma A Adams, Jeff Parker, Tony Jablonski, Joanne Kennedy, Desmond Hunter, Fiona Tasker, et al. (+9)
149 [GO] 2021―Nov―26 SARS-CoV-2 testing, infections, and hospital admissions with COVID-19 in children and young people in Scotland: a birth cohort study Graziella Favarato, Linda Wijlaars, Tom Clemens, Steve Cunningham, Bianca De Stavola, Chris Dibben, et al. (+7)
150 [GO] 2021―Nov―26 The severity of COVID-19 infection in patients with anorexia nervosa: an observational study Michael J Taylor, Uju Okereke, Robert Wilson, Anthony Winston
151 [GO] 2021―Nov―26 An exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: cross-sectional survey and qualitative analysis Jonathan Mathers, Christopher Poyner, Dean Thompson, Gavin Rudge, Ruth Pritchett
152 [GO] 2021―Nov―26 Resilience of elective cancer surgery systems during COVID-19 lockdowns: an international, multicentre, prospective cohort study
153 [GO] 2021―Nov―26 Attitudes towards COVID-19 mitigation measures implemented at St Mark's Bowel Cancer Screening Centre: a cross-sectional analysis of survey data from an ethnically diverse region in London Andrew Prentice, Ghalial Kayal, Sarah Marshall, Christian von Wagner, Robert S Kerrison
154 [GO] 2021―Nov―26 Measuring the impact of COVID-19 on sexual and reproductive health in the UK: web-panel surveys with qualitative follow-up Nigel Field, Emily Dema, Andrew J Copas, Soazig Clifton, Anne Conolly, Margaret Blake, et al. (+8)
155 [GO] 2021―Nov―26 Individuals with lived experience of homelessness and their COVID-19 outcomes in Wales: a data linkage study Jiao Song, Chris Moreno-Stokoe, Charlotte Grey, Alisha R Davies
156 [GO] 2021―Nov―26 Health protocol compliance integrated monitoring system to inform public health actions during the COVID-19 pandemic in Indonesia Dewi Nur Aisyah, Thifal Kiasatina, Gayatri I Gusti, Wiku Adisasmito, Logan Manikam, Zisis Kozlakidis
157 [GO] 2021―Nov―26 Population birth outcomes and experiences of expectant mothers during the COVID-19 pandemic in Wales: a mixed methods study Hope Jones, Mike Seaborne, Laura Cowley, David Odd, Shantini Paranjothy, Ashley Akbari, Sinead Brophy
158 [GO] 2021―Nov―26 Community-led action in response to the COVID-19 pandemic in Wales: a national, cross-sectional survey Charlotte N B Grey, Lucia Homolova, Alisha Davies
159 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on health-care usage and mental health of clinically extremely vulnerable individuals in Wales: a population-scale data linkage study Alisha Davies, Jiao Song, Ashley Akbari, Laura Bentley, Bethan Carter, Lynsey Cross, et al. (+6)
160 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on psychotropic medication uptake in Northern Ireland: a population-wide trend analysis Lisa Kent, Dermot O'Reilly, Aideen Maguire
161 [GO] 2021―Nov―26 Effects of the COVID-19 pandemic on the mental health of shielded children and children living in shielded households in Wales: a data linkage study Laura Cowley, Jiao Song, Alisha Davies
162 [GO] 2021―Nov―26 Estimating the direct and indirect risks of becoming food insecure during the COVID-19 pandemic: a cross-sectional analysis using UK cohort data Susanna Mills, Viviana Albani, Heather Brown
163 [GO] 2021―Nov―26 Understanding risk and protective factors to UK railway workers' mental wellbeing during the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Megan McGibbon, Amy Gardener, Liza Morton
164 [GO] 2021―Nov―26 The importance of adaptive coping, peer support, psychological input, team resilience, and supportive management among fire and rescue service workers in maintaining wellbeing throughout the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Amy MacDonald
165 [GO] 2021―Nov―26 Variations in the incidence of common mental disorder symptoms in the general population throughout the COVID-19 pandemic: a longitudinal cohort study Rob Saunders, Joshua Eusty Jonathan Buckman, Peter Fonagy, Stephen Pilling, Feifei Bu, Daisy Fancourt
166 [GO] 2021―Nov―26 The effect of school and peer connectedness on adolescent mental health outcomes during the COVID-19 pandemic: a longitudinal panel survey Emily Widnall, Lizzy Winstone, Ruth Plackett, Emma Adams, Claire Haworth, Becky Mars, Judi Kidger
167 [GO] 2021―Nov―26 Exploring the role of people providing informal support to survivors of domestic abuse during the COVID-19 pandemic: a qualitative study Alison Gregory, Emma Williamson
168 [GO] 2021―Nov―26 Community-led support in South Wales in response to the COVID-19 pandemic: a qualitative study with a systems-lens approach Lucia Homolova, Charlotte N B Grey, Alisha Davies
169 [GO] 2021―Nov―26 Reduced ability to engage in social and physical activity and mental health of older adults during the COVID-19 pandemic: longitudinal analysis from the Canadian Longitudinal Study on Aging Theodore D Cosco, Andrew Wister, Indira Riadi, Lucy Kervin, John Best, Parminder Raina
170 [GO] 2021―Nov―26 Scientific advice and COVID-19 policy making in the UK: an oral history study Paul Atkinson, Hayley Mableson, Sally Sheard
171 [GO] 2021―Nov―26 COVID-19 recovery from the community perspective in Middlesbrough: a coproduction cross-sectional study Andrew Divers, Catherine Parker, Parisa Diba, Clifford Johnson, Dorothy Newbury-Birch
172 [GO] 2021―Nov―26 Placing health equity at the heart of the COVID-19 recovery: data analysis from the first Welsh Health Equity Status Report initiative James Allen, Andrew Cotter-Roberts, Anna Stielke, Rajendra Kadel, Benjamin Bainham, Kathryn Ashton, et al. (+2)
173 [GO] 2021―Nov―26 Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England Huayu Zhang, Johan Thygesen, Honghan Wu
174 [GO] 2021―Nov―26 Design and implementation of a university-based COVID-19 testing programme: an observational study Claire Blackmore, Gareth W Hall, Rebecca C Allsopp, Anna L Hansell, Caroline M Cowley, Ruth C Barber, et al. (+5)
175 [GO] 2021―Nov―26 Challenges of self-isolation among contacts of cases of COVID-19: a national telephone survey in Wales Kate R Isherwood, Richard G Kyle, Benjamin J Gray, Alisha R Davies
176 [GO] 2021―Nov―26 Community-academic partnerships addressing local health inequalities during COVID-19: a qualitative evaluation Meerat Kaur, Bethany Golding, Arti Maini, Sonia Kumar
177 [GO] 2021―Nov―26 A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive? Kate Levin, Beatrix von Wissmann
178 [GO] 2021―Nov―25 COVID-19 and myocardial infarction Daniel Caldeira, Fausto J Pinto
179 [GO] 2021―Nov―25 COVID-19 and myocardial infarction - Authors' reply Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
180 [GO] 2021―Nov―25 A reproductive justice response to HIV/AIDS and COVID-19 Jallicia Jolly
181 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply N Hélène Sawadogo, Hamidou Sanou, Jeremy A Greene, Vincent Duclos
182 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa Yap Boum
183 [GO] 2021―Nov―25 Countries prepare for pandemic treaty decision John Zarocostas
184 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Chengliang Yang, Hedi Zhao, Scott J Tebbutt
185 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Yan-Jie Zhao, Wei Bai, Zhaohui Su, Chee H Ng, Yu-Tao Xiang
186 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 - Authors' reply Lixue Huang, Xiaoying Gu, Bin Cao
187 [GO] 2021―Nov―18 Legal challenges threaten Biden's COVID-19 vaccine rule Susan Jaffe
188 [GO] 2021―Nov―18 COVID-19: stigmatising the unvaccinated is not justified Günter Kampf
189 [GO] 2021―Nov―17 Studying the coagulopathy of COVID-19 Alex C Spyropoulos, Marc P Bonaca
190 [GO] 2021―Nov―17 Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6209)
191 [GO] 2021―Nov―15 Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA Saad B Omer, Regina M Benjamin, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Arthur Caplan, et al. (+16)
192 [GO] 2021―Nov―11 Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 Jing-Xin Li, Feng-Cai Zhu
193 [GO] 2021―Nov―11 Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial Rajeka Lazarus, Sarah Baos, Heike Cappel-Porter, Andrew Carson-Stevens, Madeleine Clout, Lucy Culliford, et al. (+178)
194 [GO] 2021―Nov―11 Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Pragya Yadav, Vamshi Sarangi, et al. (+23)
195 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? Sue Pavord, Marie Scully, Will Lester, Mike Makris, Beverley J Hunt
196 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors’ reply Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Magnus Nord
197 [GO] 2021―Nov―08 How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic Sudhvir Singh, Christine McNab, Rose McKeon Olson, Nellie Bristol, Cody Nolan, Elin Bergstrøm, et al. (+11)
198 [GO] 2021―Nov―04 Health experts welcome Brazil COVID-19 inquiry findings Lise Alves
199 [GO] 2021―Nov―03 Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data Lucy A McNamara, Ryan E Wiegand, Rachel M Burke, Andrea J Sharma, Michael Sheppard, Jennifer Adjemian, et al. (+16)
200 [GO] 2021―Nov―03 The value of vaccine programme impact monitoring during the COVID-19 pandemic Justin R Ortiz, Kathleen M Neuzil
201 [GO] 2021―Oct―29 Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, et al. (+2)
202 [GO] 2021―Oct―28 Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland Zoe Grange, Audrey Buelo, Christopher Sullivan, Emily Moore, Utkarsh Agrawal, Khaled Boukhari, et al. (+6)
203 [GO] 2021―Oct―28 Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, et al. (+11)
204 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation Christian Gold
205 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Samantha Vanderslott
206 [GO] 2021―Oct―28 Nowcasting towards sustainable SARS-CoV-2 endemicity Gabriel M Leung
207 [GO] 2021―Oct―22 COVID-19 and the rebiologisation of racial difference Wingel Xue, Alexandre White
208 [GO] 2021―Oct―22 Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination Kushalinii Hillson, Sue Costa Clemens, Shabir A Madhi, Merryn Voysey, Andrew J Pollard, Angela M Minassian
209 [GO] 2021―Oct―15 Developing COVID-19 vaccine policy in increments Michael S Saag
210 [GO] 2021―Oct―09 Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns Maxime Taquet, Emily A Holmes, Paul J Harrison
211 [GO] 2021―Oct―09 Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Damian F Santomauro, Ana M Mantilla Herrera, Jamileh Shadid, Peng Zheng, Charlie Ashbaugh, David M Pigott, et al. (+61)
212 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, John H Alexander, Otavio Berwanger
213 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
214 [GO] 2021―Oct―08 The path to global equity in mental health care in the context of COVID-19 Lola Kola, Brandon A Kohrt, Bibhav Acharya, Byamah B Mutamba, Christian Kieling, Manasi Kumar, et al. (+3)
215 [GO] 2021―Oct―07 Can COVID-19 help accelerate and transform the diagnostics agenda? Sabine Kleinert, Richard Horton
216 [GO] 2021―Oct―05 Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, et al. (+9)
217 [GO] 2021―Oct―05 Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore Chuan De Foo, Karen A Grépin, Alex R Cook, Li Yang Hsu, Michael Bartos, Sudhvir Singh, et al. (+4)
218 [GO] 2021―Oct―05 Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients Maria Prendecki, Tina Thomson, Candice L Clarke, Paul Martin, Sarah Gleeson, Rute Cardoso De Aguiar, et al. (+11)
219 [GO] 2021―Sep―30 Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, et al. (+10)
220 [GO] 2021―Sep―30 COVID-19 research in LMICs Ivan Sisa, Marco Fornasini, Enrique Teran
221 [GO] 2021―Sep―30 COVID-19 research in LMICs - Authors' reply Irene Torres, Barbara Profeta, Cristiani Vieira Machado, Osvaldo Artaza, Daniel Lopez-Cevallos, JaHyun Kang
222 [GO] 2021―Sep―29 World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease Fausto J Pinto, Daniel Piñeiro, Amitava Banerjee, Pablo Perel, Borjana Pervan, Jean-Luc Eiselé
223 [GO] 2021―Sep―29 ECMO in COVID-19: do not blame the tool Alain Vuylsteke
224 [GO] 2021―Sep―24 Functioning of the International Health Regulations during the COVID-19 pandemic Preben Aavitsland, Ximena Aguilera, Seif Salem Al-Abri, Vincent Amani, Carmen C Aramburu, Thouraya A Attia, et al. (+13)
225 [GO] 2021―Sep―23 Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050 Angela E Micah, Ian E Cogswell, Brandon Cunningham, Satoshi Ezoe, Anton C Harle, Emilie R Maddison, et al. (+407)
226 [GO] 2021―Sep―23 COVID-19: learning as an interdependent world The Lancet
227 [GO] 2021―Sep―22 The long-term impact of COVID-19 on development assistance for health is still uncertain Osondu Ogbuoji, Wenhui Mao, Genevieve Aryeetey
228 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 Jacques van Helden, Colin D Butler, Guillaume Achaz, Bruno Canard, Didier Casane, Jean-Michel Claverie, et al. (+10)
229 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply Gerald T Keusch, Sai Kit Lam, John S Mackenzie, Linda Saif, Michael Turner
230 [GO] 2021―Sep―17 SARS-CoV-2's origin should be investigated worldwide for pandemic prevention Zhiqiang Wu, Qi Jin, Guizhen Wu, Jian Lu, Mingkun Li, Deyin Guo, et al. (+9)
231 [GO] 2021―Sep―14 Considerations in boosting COVID-19 vaccine immune responses Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, et al. (+12)
232 [GO] 2021―Sep―14 Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial Bernadette C Young, David W Eyre, Saroj Kendrick, Chris White, Sylvester Smith, George Beveridge, et al. (+25)
233 [GO] 2021―Sep―10 A new strategy for health and sustainable development in the light of the COVID-19 pandemic Mario Monti, Aleksandra Torbica, Elias Mossialos, Martin McKee
234 [GO] 2021―Sep―02 The long road ahead for COVID-19 vaccination in Africa Sara Jerving
235 [GO] 2021―Sep―02 The race to make a COVID-19 vaccine Sarah Boseley
236 [GO] 2021―Sep―01 Global youth advocating for COVID-19 vaccines for all Neema Kaseje, David Walcott
237 [GO] 2021―Sep―01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K Aley, Brian Angus, et al. (+181)
238 [GO] 2021―Sep―01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine Elizabeth T Rogawski McQuade, Alexander Breskin
239 [GO] 2021―Aug―26 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al. (+19)
240 [GO] 2021―Aug―24 Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic Arghavan Salles, Reshma Jagsi
241 [GO] 2021―Aug―17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination Georg MN Behrens, Anne Cossmann, Metodi V Stankov, Inga Nehlmeier, Amy Kempf, Markus Hoffmann, Stefan Pöhlmann
242 [GO] 2021―Aug―13 Tackling Latin America's COVID-19 emergency requires greater solidarity Carissa F Etienne
243 [GO] 2021―Aug―13 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave Jonathan M Read, Chris A Green, Ewen M Harrison, Annemarie B Docherty, Sebastian Funk, Janet Harrison, et al. (+8)
244 [GO] 2021―Aug―13 Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Emma C Wall, Gavin Kelly, Saira Hussain, et al. (+78)
245 [GO] 2021―Aug―12 SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Pat O’Brien, Asma Khalil
246 [GO] 2021―Aug―10 The use of inhaled corticosteroids in early-stage COVID-19 Dee Mangin, Michelle Howard
247 [GO] 2021―Aug―10 Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, et al. (+46)
248 [GO] 2021―Aug―10 Serial intervals in SARS-CoV-2 B.1.617.2 variant cases Rachael Pung, Tze Minn Mak, Adam J Kucharski, Vernon J Lee
249 [GO] 2021―Aug―09 Towards a European strategy to address the COVID-19 pandemic Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, Sarah Cuschieri, et al. (+22)
250 [GO] 2021―Aug―06 Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj, et al. (+70)
251 [GO] 2021―Aug―06 Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+82)
252 [GO] 2021―Aug―06 Optimising SARS-CoV-2 vaccination schedules Cristobal Belda-Iniesta
253 [GO] 2021―Aug―05 COVID-19, online shaming, and health-care professionals Luna Dolezal, Arthur Rose, Fred Cooper
254 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data Luigi Pisani, Wangari Waweru-Siika, Cornelius Sendagire, Abi Beane, Rashan Haniffa
255 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply Bruce M Biccard, David Thomson, Malcolm Miller, Elliott H Taylor, P Dean Gopalan
256 [GO] 2021―Aug―04 Mucormycosis after COVID-19 in a patient with diabetes Khushboo Chauhan, Deepak Soni, Deepayan Sarkar, Tadepalli Karuna, Bhavana Sharma, Sarman Singh, Samendra Karkhur
257 [GO] 2021―Jul―30 COVID-19 vaccines for children in LMICs: another equity issue Beate Kampmann, Uduak Okomo
258 [GO] 2021―Jul―29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
259 [GO] 2021―Jul―29 What is the association of COVID-19 with heart attacks and strokes? Marion Mafham, Colin Baigent
260 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? Daniel Pan, Christopher A Martin, Joshua Nazareth, Clareece R Nevill, Jatinder S Minhas, Pip Divall, et al. (+5)
261 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply Rohini Mathur, Christopher T Rentsch, Caroline E Morton, Rosalind M Eggo, Krishnan Bhaskaran, Laurie Tomlinsonn, et al. (+2)
262 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? Carel IJsselmuiden, Francine Ntoumi, James V Lavery, Jaime Montoya, Salim Abdool Karim, Kirsty Kaiser
263 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? - Authors' reply Nicole Lurie, Gerald T Keusch, Victor J Dzau
264 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov
265 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Chengliang Yang, Hedi Zhao
266 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply Peter Horby, Natalie Staplin, Richard Haynes, Martin Landray
267 [GO] 2021―Jul―21 Answering the call to support youth orphaned by COVID-19 Rachel A Kentor, Amanda L Thompson
268 [GO] 2021―Jul―21 Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond Alejandra Jáuregui, Estelle Victoria Lambert, Jenna Panter, Clover Moore, Deborah Salvo
269 [GO] 2021―Jul―21 Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study Susan D Hillis, H Juliette T Unwin, Yu Chen, Lucie Cluver, Lorraine Sherr, Philip S Goldman, et al. (+10)
270 [GO] 2021―Jul―20 Will the COVID-19 crisis catalyse universal health reforms? Lucinda Hiam, Robert Yates
271 [GO] 2021―Jul―20 COVID-19: the turning point for gender equality Senait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Debora Diniz, Henrietta H Fore, et al. (+11)
272 [GO] 2021―Jul―17 In-hospital complications associated with COVID-19 Xiaoying Gu, Bin Cao
273 [GO] 2021―Jul―17 COVID-19 in Africa: a lesson in solidarity The Lancet
274 [GO] 2021―Jul―17 Disruptions to childhood immunisation due to the COVID-19 pandemic Kaja Abbas, Vittal Mogasale
275 [GO] 2021―Jul―17 Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study Kate Causey, Nancy Fullman, Reed J D Sorensen, Natalie C Galles, Peng Zheng, Aleksandr Aravkin, et al. (+12)
276 [GO] 2021―Jul―17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya M Riad, Cameron J Fairfield, Conor Egan, Stephen R Knight, Riinu Pius, et al. (+397)
277 [GO] 2021―Jul―17 COVID-19: counting migrants in Sally Hargreaves, Sally E Hayward, Teymur Noori, Martin McKee, Bernadette Kumar
278 [GO] 2021―Jul―08 COVID-19 in Latin America-emergency and opportunity The Lancet
279 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region Khuloud Alsaba
280 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
281 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines Bram Rochwerg, Thomas Agoritsas, Janet Diaz, Lisa Askie
282 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines - Authors' reply Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
283 [GO] 2021―Jul―08 Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, Hatice Rahmet Güner, Alpay Azap, Sıla Akhan, et al. (+70)
284 [GO] 2021―Jul―06 7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics Thomas R Frieden, Christopher T Lee, Aaron F Bochner, Marine Buissonnière, Amanda McClelland
285 [GO] 2021―Jul―05 Science, not speculation, is essential to determine how SARS-CoV-2 reached humans Charles H Calisher, Dennis Carroll, Rita Colwell, Ronald B Corley, Peter Daszak, Christian Drosten, et al. (+18)
286 [GO] 2021―Jul―01 Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis Kirsten R Palmer, Michael Tanner, Miranda Davies-Tuck, Andrea Rindt, Kerrie Papacostas, Michelle L Giles, et al. (+9)
287 [GO] 2021―Jul―01 Sparks through the stubble: dying in a pandemic Rachel Clarke
288 [GO] 2021―Jul―01 Learning from crisis: building resilient systems to combat future pandemics Ilona Kickbusch, Gabriel M Leung, Robin J Shattock
289 [GO] 2021―Jun―28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+18)
290 [GO] 2021―Jun―25 Heterologous vaccine regimens against COVID-19 Talita Duarte-Salles, Daniel Prieto-Alhambra
291 [GO] 2021―Jun―25 What constitutes success in the roll-out of COVID-19 vaccines? Maxwell J Smith
292 [GO] 2021―Jun―25 Pandemic response requires early and robust verification Susanna Lehtimaki, Pascale Allotey, Nina Schwalbe
293 [GO] 2021―Jun―25 More social discontent than pandemic-related risk perception in Colombia Alvaro J Idrovo
294 [GO] 2021―Jun―24 India's pain: beyond COVID-19 case numbers and mortality rates Rohini Dutta, Tarinee Kucchal
295 [GO] 2021―Jun―24 Can India's COVID-19 emergency be fixed without politics? Kunal Saha
296 [GO] 2021―Jun―24 India's COVID-19 emergency: overarching conclusions belie facts Dhavendra Kumar, Madhukar Mittal
297 [GO] 2021―Jun―24 India's COVID-19 response: science first Nita Radhakrishnan, Devendra Kumar Gupta
298 [GO] 2021―Jun―24 The complex causes of India's 2021 COVID-19 surge Aayush Visaria, Tina Dharamdasani
299 [GO] 2021―Jun―21 Addendum: competing interests and the origins of SARS-CoV-2 Editors of The Lancet
300 [GO] 2021―Jun―18 Five priorities for universal COVID-19 vaccination Adrien Abecassis
301 [GO] 2021―Jun―17 Protecting refugees during the COVID-19 pandemic The Lancet
302 [GO] 2021―Jun―14 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness Aziz Sheikh, Jim McMenamin, Bob Taylor, Chris Robertson
303 [GO] 2021―Jun―11 SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban Katharina Guetl, Thomas Gary, Reinhard B Raggam, Johannes Schmid, Albert Wölfler, Marianne Brodmann
304 [GO] 2021―Jun―10 Narrative complexity in the time of COVID-19 Aline Gubrium, Erika Gubrium
305 [GO] 2021―Jun―10 From routine data collection to policy design: sex and gender both matter in COVID-19 Mireille Evagora-Campbell, Kakoli Borkotoky, Sneha Sharma, Michelle Mbuthia
306 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
307 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? John F R Robertson, Herb F Sewell
308 [GO] 2021―Jun―10 Anticoagulation in COVID-19: reaction to the ACTION trial Jeffrey S Berger, Jean Marie Connors
309 [GO] 2021―Jun―10 A strategy for SARS-CoV-2 vaccination in Yemen Abdullah Nasser, Fathiah Zakham
310 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates Elizabeth T Rogawski McQuade, James A Platts-Mills
311 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply Merryn Voysey, Andrew J Pollard
312 [GO] 2021―Jun―08 Epidemiology, not geopolitics, should guide COVID-19 vaccine donations Thomas J Bollyky, Christopher J L Murray, Robert C Reiner
313 [GO] 2021―Jun―05 Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19 Emily Ying Yang Chan, Nina Gobat, Caroline Dubois, Jamie Bedson, Joao Rangel de Almeida
314 [GO] 2021―Jun―05 Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, et al. (+42)
315 [GO] 2021―Jun―03 The CEPI centralised laboratory network: supporting COVID-19 vaccine development Arun Kumar, Valentina Bernasconi, Mark Manak, Ana Paula de Almeida Aranha, Paul A Kristiansen
316 [GO] 2021―Jun―03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+19)
317 [GO] 2021―Jun―02 Delayed COVID-19 vaccine roll-out in Japan Makoto Kosaka, Takanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto, Masahiro Kami
318 [GO] 2021―Jun―01 A pandemic anniversary: 40 years of HIV/AIDS Chris Beyrer
319 [GO] 2021―May―29 Africa's need for more COVID-19 clinical trials Munyaradzi Makoni
320 [GO] 2021―May―29 Cambodia ends controversial COVID-19 restrictions Megan Tatum
321 [GO] 2021―May―28 Mutual aid, pandemic politics, and global social medicine in Brazil Dominique Béhague, Francisco Ortega
322 [GO] 2021―May―25 India's resurgence of COVID-19: urgent actions needed Yamini Aiyar, Vijay Chandru, Mirai Chatterjee, Sapna Desai, Armida Fernandez, Atul Gupta, et al. (+15)
323 [GO] 2021―May―21 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study Bruce M Biccard, Pragasan Dean Gopalan, Malcolm Miller, William Lance Michell, David Thomson, Adesoji Ademuyiwa, et al. (+226)
324 [GO] 2021―May―21 What next for a COVID-19 intellectual property waiver? John Zarocostas
325 [GO] 2021―May―21 Excess COVID-19 mortality among critically ill patients in Africa Bruce J Kirenga, Pauline Byakika-Kibwika
326 [GO] 2021―May―21 Gendered effects of COVID-19 on young girls in regions of conflict Sophia N Nesamoney, Gary L Darmstadt, Paul H Wise
327 [GO] 2021―May―21 Refugee access to COVID-19 vaccines in Lebanon Nadine K Jawad, Lina Abu Taweeleh, Jad A Elharake, Nicole Khamis, Osaid Alser, Fatima M Karaki, Layla Aboukhater
328 [GO] 2021―May―14 India's COVID-19 crisis: a call for international action Krutika Kuppalli, Pooja Gala, Kartikeya Cherabuddi, S P Kalantri, Manoj Mohanan, Bhramar Mukherjee, et al. (+7)
329 [GO] 2021―May―14 Convalescent plasma in patients hospitalised with COVID-19 Sean T H Liu, Judith A Aberg
330 [GO] 2021―May―14 Disease surveillance for the COVID-19 era: time for bold changes Oliver W Morgan, Ximena Aguilera, Andrea Ammon, John Amuasi, Ibrahima Socé Fall, Tom Frieden, et al. (+10)
331 [GO] 2021―May―14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+7188)
332 [GO] 2021―May―13 COVID-19 in Turkey: a nation on edge Kaya Genç
333 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Philipp Enghard, Jan-Hendrik Hardenberg, Helena Stockmann, Christian Hinze, Kai-Uwe Eckardt, Kai M Schmidt-Ott
334 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Pierre Delanaye, Justine Huart, Antoine Bouquegneau, François Jouret
335 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function - Authors' reply Lixue Huang, Xiaoying Gu, Yeming Wang, Chaolin Huang, Bin Cao
336 [GO] 2021―May―13 Serbia begins paying citizens to receive a COVID-19 vaccine Ed Holt
337 [GO] 2021―May―13 Canada is no global health leader on COVID-19 vaccine equity Adam R Houston, Srinivas Murthy
338 [GO] 2021―May―13 Global COVID-19 vaccine roll-out: time to randomise vaccine allocation? Samuel I Watson, Richard J Lilford
339 [GO] 2021―May―13 Venezuela is collapsing without COVID-19 vaccines Enrique S López Loyo, Marino J González, José Esparza
340 [GO] 2021―May―12 Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic Ellen Johnson Sirleaf, Helen Clark
341 [GO] 2021―May―12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam, Matthew D Snape
342 [GO] 2021―May―07 LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19 Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, et al. (+28)
343 [GO] 2021―May―07 India's COVID-19 emergency The Lancet
344 [GO] 2021―May―07 Priorities for COVID-19 research response and preparedness in low-resource settings Alice Joan Norton, Charles Shey Wiysonge, Jean-Marie Vianney Habarugira, Nicholas John White, Marta Tufet Bayona, Hans-Eckhardt Hagen, et al. (+19)
345 [GO] 2021―May―07 COVID-19 surge threatens health in the Gaza strip Sharmila Devi
346 [GO] 2021―May―06 UK guidelines for managing long-term effects of COVID-19 Waqaar Shah, Melissa Heightman, Stella O'Brien
347 [GO] 2021―May―06 No-fault compensation schemes for COVID-19 medical products Yasuhiro Fujiwara, Yutaka Onda, Shuichiro Hayashi
348 [GO] 2021―May―05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, et al. (+9)
349 [GO] 2021―May―05 COVID-19 vaccine impact in Israel and a way out of the pandemic Eyal Leshem, Annelies Wilder-Smith
350 [GO] 2021―Apr―30 Experts criticise India's complacency over COVID-19 Anoo Bhuyan
351 [GO] 2021―Apr―30 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6343)
352 [GO] 2021―Apr―30 Tocilizumab in COVID-19: some clarity amid controversy Shruti Gupta, David E Leaf
353 [GO] 2021―Apr―30 COVID-19 and disparities affecting ethnic minorities Daniel R Morales, Sarah N Ali
354 [GO] 2021―Apr―30 Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform Rohini Mathur, Christopher T Rentsch, Caroline E Morton, William J Hulme, Anna Schultze, Brian MacKenna, et al. (+31)
355 [GO] 2021―Apr―28 SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, et al. (+2)
356 [GO] 2021―Apr―28 A global pandemic treaty should aim for deep prevention Jorge Vinuales, Suerie Moon, Ginevra Le Moli, Gian-Luca Burci
357 [GO] 2021―Apr―23 COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, et al. (+349)
358 [GO] 2021―Apr―23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study Eleftheria Vasileiou, Colin R Simpson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari, et al. (+26)
359 [GO] 2021―Apr―23 Hospital admissions due to COVID-19 in Scotland after one dose of vaccine Natalie Dean
360 [GO] 2021―Apr―20 The Swedish COVID-19 strategy revisited Mariam Claeson, Stefan Hanson
361 [GO] 2021―Apr―17 COVID-19: time for ethical reflection? Henri-Corto Stoeklé, Achille Ivasilevitch, Christian Hervé
362 [GO] 2021―Apr―16 Brazilian ICUs short of drugs and beds amid COVID-19 surge Lise Alves
363 [GO] 2021―Apr―16 Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley
364 [GO] 2021―Apr―16 Pandemic reading: poetry, looking and seeing Belinda Jack
365 [GO] 2021―Apr―15 Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Suraj Kadiwar, Jonathan J Smith, Stephane Ledot, Mark Johnson, Paolo Bianchi, Natasha Singh, et al. (+4)
366 [GO] 2021―Apr―15 Tanzania's position on the COVID-19 pandemic Sayoki G Mfinanga, Nicholaus P Mnyambwa, Daniel T Minja, Nyanda Elias Ntinginya, Esther Ngadaya, Julie Makani, Abel N Makubi
367 [GO] 2021―Apr―15 Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination Antonios Bayas, Martina Menacher, Monika Christ, Lars Behrens, Andreas Rank, Markus Naumann
368 [GO] 2021―Apr―09 Correlates of protection from SARS-CoV-2 infection Florian Krammer
369 [GO] 2021―Apr―09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Jane Hall, Sarah Foulkes, Andre Charlett, Ana Atti, Edward J Monk, Ruth Simmons, et al. (+323)
370 [GO] 2021―Apr―08 US-China health exchange and collaboration following COVID-19 Liming Li, Kean Wang, Zhuo Chen, Jeffrey P Koplan
371 [GO] 2021―Apr―08 China's response to COVID-19: a chance for collaboration The Lancet
372 [GO] 2021―Apr―08 Calls for transparency after SARS-CoV-2 origins report John Zarocostas
373 [GO] 2021―Apr―07 Ramadan and COVID-19 vaccine hesitancy-a call for action Sarah N Ali, Wasim Hanif, Kiran Patel, Kamlesh Khunti
374 [GO] 2021―Apr―02 Migration and health in Latin America during the COVID-19 pandemic and beyond Ietza Bojorquez, Báltica Cabieses, Carlos Arósquipa, Juan Arroyo, Andrés Cubillos Novella, Michael Knipper, et al. (+3)
375 [GO] 2021―Apr―02 COVID-19 vaccines in high-risk ethnic groups Rashmi S D'Souza, Ingrid Wolfe
376 [GO] 2021―Apr―02 Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 Justin E R E Wong Chung, Ö Engin, T F W Wolfs, T J C Renson, J H de Boer
377 [GO] 2021―Apr―02 Leveraging data and new digital tools to prepare for the next pandemic Sally C Davies, Hala Audi, Mitch Cuddihy
378 [GO] 2021―Mar―31 Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence? Søren Dinesen Østergaard, Morten Schmidt, Erzsébet Horváth-Puhó, Reimar Wernich Thomsen, Henrik Toft Sørensen
379 [GO] 2021―Mar―31 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, Cristina V Ariani, Brian Angus, Sagida Bibi, et al. (+58)
380 [GO] 2021―Mar―31 Pandemic moves and countermoves: vaccines and viral variants Rogier W Sanders, Menno D de Jong
381 [GO] 2021―Mar―25 COVID-19, cults, and the anti-vax movement Sophie Mylan, Charlotte Hardman
382 [GO] 2021―Mar―25 New COVID-19 resurgence in the WHO Eastern Mediterranean region Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
383 [GO] 2021―Mar―25 Uncertainties over EU COVID-19 vaccine sharing scheme Ann Danaiya Usher
384 [GO] 2021―Mar―25 COVID-19 vaccines for the European region: an unprecedented challenge Hans Kluge, Martin McKee
385 [GO] 2021―Mar―25 COVID-19: building a stronger Europe The Lancet
386 [GO] 2021―Mar―24 Gender, race, and health workers in the COVID-19 pandemic Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham
387 [GO] 2021―Mar―24 Africa needs local solutions to face the COVID-19 pandemic Yap Boum, Lisa M Bebell, Anne-Cécile Zoung-Kanyi Bisseck
388 [GO] 2021―Mar―24 The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study Stephanie J Salyer, Justin Maeda, Senga Sembuche, Yenew Kebede, Akhona Tshangela, Mohamed Moussif, et al. (+5)
389 [GO] 2021―Mar―24 Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights Chris Beyrer, Pascale Allotey, Joseph J Amon, Stefan D Baral, Mary T Bassett, Harriet Deacon, et al. (+17)
390 [GO] 2021―Mar―23 Guidelines should not pool evidence from uncomplicated and severe COVID-19 Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
391 [GO] 2021―Mar―23 Assessing government responsibility for COVID-19 deaths Adrian P Mundt
392 [GO] 2021―Mar―23 Rapid identification and tracking of SARS-CoV-2 variants of concern Debojyoti Chakraborty, Anurag Agrawal, Souvik Maiti
393 [GO] 2021―Mar―23 Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection Salim S Abdool Karim
394 [GO] 2021―Mar―19 Biden's first legislative victory: $1·9 trillion for COVID-19 Susan Jaffe
395 [GO] 2021―Mar―19 COVID-19, community trials, and inclusion Paramjit S Gill, Shoba Poduval, Jarnail S Thakur, Romaina Iqbal
396 [GO] 2021―Mar―19 Free licensing of vaccines to end the COVID-19 crisis Kayvan Bozorgmehr, Rosa Jahn, David Stuckler, Martin McKee
397 [GO] 2021―Mar―19 Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2 Richard Strugnell, Nancy Wang
398 [GO] 2021―Mar―18 Triple jeopardy: disabled people and the COVID-19 pandemic Tom Shakespeare, Florence Ndagire, Queen E Seketi
399 [GO] 2021―Mar―18 Malnutrition risk in hospitalised COVID-19 patients receiving CPAP Pete Turner, Hugh Montgomery, Mike Stroud, George Grimble, Trevor Smith
400 [GO] 2021―Mar―18 Missing again: US racial and ethnic data for COVID-19 vaccination Nancy Krieger, Pamela D Waterman, Jarvis T Chen, Christian Testa, William P Hanage
401 [GO] 2021―Mar―18 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study Christian Holm Hansen, Daniela Michlmayr, Sophie Madeleine Gubbels, Kåre Mølbak, Steen Ethelberg
402 [GO] 2021―Mar―18 Risk of SARS-CoV-2 reinfection after natural infection Rosemary J Boyton, Daniel M Altmann
403 [GO] 2021―Mar―12 School reopening without robust COVID-19 mitigation risks accelerating the pandemic Deepti Gurdasani, Nisreen A Alwan, Trisha Greenhalgh, Zoë Hyde, Luke Johnson, Martin McKee, et al. (+6)
404 [GO] 2021―Mar―12 A shared COVID-19 testimony Rageshri Dhairyawan
405 [GO] 2021―Mar―12 Countries split from EU on COVID-19 vaccines Ed Holt
406 [GO] 2021―Mar―12 Access to COVID-19 vaccines: looking beyond COVAX The Lancet
407 [GO] 2021―Mar―09 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine Julie Steinberg, Alex Thomas, Amir Iravani
408 [GO] 2021―Mar―07 The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response Syra Madad, Craig Spencer
409 [GO] 2021―Mar―07 Sex-disaggregated data in COVID-19 vaccine trials Lavanya Vijayasingham, Evelyne Bischof, Jeannette Wolfe
410 [GO] 2021―Mar―05 Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher C Butler, Jienchi Dorward, Ly-Mee Yu, Oghenekome Gbinigie, Gail Hayward, Benjamin R Saville, et al. (+12)
411 [GO] 2021―Mar―05 Medical oxygen crisis: a belated COVID-19 response Ann Danaiya Usher
412 [GO] 2021―Mar―05 Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster Ivan F N Hung, Gregory A Poland
413 [GO] 2021―Feb―26 New WTO leader faces COVID-19 challenges John Zarocostas
414 [GO] 2021―Feb―26 Historical evidence to inform COVID-19 vaccine mandates Rajaie Batniji
415 [GO] 2021―Feb―26 Peruvian COVID-19 vaccine scandal spreads Lucien Chauvin
416 [GO] 2021―Feb―26 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine Maria Prendecki, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, et al. (+8)
417 [GO] 2021―Feb―26 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals Charlotte Manisty, Ashley D Otter, Thomas A Treibel, Áine McKnight, Daniel M Altmann, Timothy Brooks, et al. (+4)
418 [GO] 2021―Feb―26 Offline: Thinking the pandemic Richard Horton
419 [GO] 2021―Feb―24 The changing face of medical professionalism and the impact of COVID-19 Andrew F Goddard, Mumtaz Patel
420 [GO] 2021―Feb―24 UK COVID-19 public inquiry and lessons from patient safety David K Whitaker
421 [GO] 2021―Feb―21 Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
422 [GO] 2021―Feb―21 MAb for symptomatic COVID-19 in correctional facilities: an important opportunity Justin Berk, Lauren Brinkley-Rubinstein, Matthew Murphy, Phil Chan, Josiah Rich
423 [GO] 2021―Feb―21 Same script, different viruses: HIV and COVID-19 in US Black communities Errol L Fields, Raniyah Copeland, Ernest Hopkins
424 [GO] 2021―Feb―21 von der Leyen admits to COVID-19 vaccine failures Rob Hyde
425 [GO] 2021―Feb―21 Severe mental illness: reassessing COVID-19 vaccine priorities Nayanah Siva
426 [GO] 2021―Feb―21 Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs Ivan Sisa, Estefania Noblecilla, Fadya Orozco
427 [GO] 2021―Feb―21 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+760)
428 [GO] 2021―Feb―18 Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 Michael J Mina, Tim E Peto, Marta García-Fiñana, Malcolm G Semple, Iain E Buchan
429 [GO] 2021―Feb―17 Future scenarios for the COVID-19 pandemic David Skegg, Peter Gluckman, Geoffrey Boulton, Heide Hackmann, Salim S Abdool Karim, Peter Piot, Christiane Woopen
430 [GO] 2021―Feb―15 Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment Olivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad, Andrew J Pollard, Heidi J Larson, Yot Teerawattananon, Mark Jit
431 [GO] 2021―Feb―15 Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission Jeffrey D Sachs, Salim Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, et al. (+30)
432 [GO] 2021―Feb―11 COVID-19 in Brazil: far beyond biopolitics Rafael Dall'Alba, Cristianne Famer Rocha, Roberta de Pinho Silveira, Liciane da Silva Costa Dresch, Luciana Araújo Vieira, Marco André Germanò
433 [GO] 2021―Feb―11 SARS-CoV-2 variants and ending the COVID-19 pandemic Arnaud Fontanet, Brigitte Autran, Bruno Lina, Marie Paule Kieny, Salim S Abdool Karim, Devi Sridhar
434 [GO] 2021―Feb―11 Tanzania refuses COVID-19 vaccines Munyaradzi Makoni
435 [GO] 2021―Feb―10 Ensure Palestinians have access to COVID-19 vaccines Steven Martin, Thalia Arawi
436 [GO] 2021―Feb―05 Offline: COVID-19 and the convergence of nations Richard Horton
437 [GO] 2021―Feb―05 Calling for benefit-risk evaluations of COVID-19 control measures Günter Kampf, Martin Kulldorff
438 [GO] 2021―Feb―05 A COVID-19 jab in the right direction A Mark Clarfield, Karl Skorecki, Orly Manor, Shimon Glick
439 [GO] 2021―Feb―05 WHO team begins COVID-19 origin investigation John Zarocostas
440 [GO] 2021―Feb―05 WHO international non-proprietary names: the need to distinguish COVID-19 vaccines Ursula Loizides, Akinola Adisa, Ana López de la Rica Manjavacas, James S Robertson, Raffaella Balocco
441 [GO] 2021―Feb―05 Understanding variants of SARS-CoV-2 Talha Burki
442 [GO] 2021―Feb―05 Genomic sequencing in pandemics The Lancet
443 [GO] 2021―Feb―05 Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, Alfie Abbott, Ashraf Abdelaziz, Sherif Abdelbadiee, et al. (+5364)
444 [GO] 2021―Feb―02 COVID-19, structural racism, and migrant health in Canada Germaine Tuyisenge, Shira M Goldenberg
445 [GO] 2021―Feb―02 Sputnik V COVID-19 vaccine candidate appears safe and effective Ian Jones, Polly Roy
446 [GO] 2021―Feb―02 COVID-19 vaccine research and the trouble with clinical equipoise Phoebe Friesen, Arthur L Caplan, Jennifer E Miller
447 [GO] 2021―Feb―02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, et al. (+25)
448 [GO] 2021―Jan―29 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, et al. (+5)
449 [GO] 2021―Jan―29 Next-generation COVID-19 vaccines: here come the proteins Anna K Blakney, Paul F McKay
450 [GO] 2021―Jan―28 Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics J Peter Figueroa, Maria Elena Bottazzi, Peter Hotez, Carolina Batista, Onder Ergonul, Sarah Gilbert, et al. (+12)
451 [GO] 2021―Jan―28 COVID-19 vaccines for Palestinians Graham Watt, Rita Giacaman, Huda Zurayk, Espen Bjertness, Gerd Holmboe-Ottesen, Hala Ghattas, et al. (+8)
452 [GO] 2021―Jan―28 Caring intensively: a GP's pandemic journal Rachel Clarke
453 [GO] 2021―Jan―28 SARS-CoV-2 serosurveys in low-income and middle-income countries Jean Claude Mugunga, Kartik Tyagi, Daniel Bernal-Serrano, Nidia Correa, Matias Iberico, Frederick Kateera, et al. (+4)
454 [GO] 2021―Jan―27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Ester C Sabino, Lewis F Buss, Maria P S Carvalho, Carlos A Prete, Myuki A E Crispim, Nelson A Fraiji, et al. (+17)
455 [GO] 2021―Jan―25 The need for a global COVID-19 maternal immunisation research plan Azucena Bardají, Esperança Sevene, Clare Cutland, Clara Menéndez, Saad B Omer, Teresa Aguado, Flor M Muñoz
456 [GO] 2021―Jan―22 COVID-19 and the moral imagination Mahomed Said Patel, Christine Beatrice Phillips
457 [GO] 2021―Jan―22 Reaffirming health and safety precautionary principles for COVID-19 in the UK Raymond M Agius, Denise Kendrick, Herb F Sewell, Marcia Stewart, John FR Robertson
458 [GO] 2021―Jan―22 India begins COVID-19 vaccination amid trial allegations Anoo Bhuyan
459 [GO] 2021―Jan―22 COVID-19: the intersection of education and health The Lancet
460 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Kristof Egervari, Christian Thomas, Johannes A Lobrinus, Tanja Kuhlmann, Wolfgang Brück, Seth Love, et al. (+4)
461 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection MacLean P Nasrallah, Zissimos Mourelatos, Edward B Lee
462 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Markus Glatzel, Christian Hagel, Jakob Matschke, Jan Sperhake, Nikolaus Deigendesch, Alexandar Tzankov, Stephan Frank
463 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection - Authors' reply Claus Hann von Weyhern, Ines Kaufmann, Frauke Neff, Marcus Kremer
464 [GO] 2021―Jan―22 South Africa responds to new SARS-CoV-2 variant Munyaradzi Makoni
465 [GO] 2021―Jan―21 An action plan for pan-European defence against new SARS-CoV-2 variants Viola Priesemann, Rudi Balling, Melanie M Brinkmann, Sandra Ciesek, Thomas Czypionka, Isabella Eckerle, et al. (+11)
466 [GO] 2021―Jan―20 Preparing for a COVID-19 resurgence in the WHO African region Benido Impouma, Franck Mboussou, Francis Kasolo, Zabulon Yoti, Matshidiso R Moeti
467 [GO] 2021―Jan―15 COVID-19 highlights Canada's care home crisis Paul Webster
468 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology Marisa Dolhnikoff, Amaro N Duarte-Neto, Paulo H N Saldiva, Elia G Caldini
469 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology - Authors' reply Carsten Dittmayer, Jenny Meinhardt, Helena Radbruch, Josefine Radke, Barbara Ingold Heppner, Frank L Heppner, et al. (+3)
470 [GO] 2021―Jan―14 The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines Marco Cavaleri, Harald Enzmann, Sabine Straus, Emer Cooke
471 [GO] 2021―Jan―11 Long-term follow-up of recovered patients with COVID-19 Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
472 [GO] 2021―Jan―11 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, et al. (+26)
473 [GO] 2021―Jan―08 Parenting in the time of COVID-19 Shana Kusin, Esther Choo
474 [GO] 2021―Jan―08 Health systems neglected by COVID-19 donors Ann Danaiya Usher
475 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act Yang Zhang, Bingyang Ji, Zhou Zhou
476 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act - Authors' reply Ryan P Barbaro, Graeme MacLaren, Daniel Brodie
477 [GO] 2020―Dec―23 COVID-19 and the Swedish enigma Mariam Claeson, Stefan Hanson
478 [GO] 2020―Dec―23 UK COVID-19 public inquiry needed to learn lessons and save lives Jo Goodman, Kathryn de Prudhoe, Charlie Williams
479 [GO] 2020―Dec―23 COVID-19 vaccines and women's security Sophie Harman, Asha Herten-Crabb, Rosemary Morgan, Julia Smith, Clare Wenham
480 [GO] 2020―Dec―18 Offline: The lessons of smallpox eradication for COVID-19 Richard Horton
481 [GO] 2020―Dec―18 Infectivity of asymptomatic versus symptomatic COVID-19 Andrew A Sayampanathan, Cheryl S Heng, Phua Hwee Pin, Junxiong Pang, Teoh Yee Leong, Vernon J Lee
482 [GO] 2020―Dec―18 Science during COVID-19: where do we go from here? The Lancet
483 [GO] 2020―Dec―18 Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections Viola Priesemann, Melanie M Brinkmann, Sandra Ciesek, Sarah Cuschieri, Thomas Czypionka, Giulia Giordano, et al. (+14)
484 [GO] 2020―Dec―16 Pay gaps in medicine and the impact of COVID-19 on doctors' careers Carol Woodhams, Jane Dacre, Ira Parnerkar, Mukunda Sharma
485 [GO] 2020―Dec―16 Reduced mortality in New Zealand during the COVID-19 pandemic Stacey Kung, Marjan Doppen, Melissa Black, Tom Hills, Nethmi Kearns
486 [GO] 2020―Dec―16 Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests Meagan C Fitzpatrick, Abhishek Pandey, Chad R Wells, Pratha Sah, Alison P Galvani
487 [GO] 2020―Dec―11 Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic Berit Lange
488 [GO] 2020―Dec―11 Experts call to include prisons in COVID-19 vaccine plans Nayanah Siva
489 [GO] 2020―Dec―11 The COVID-19 vaccines rush: participatory community engagement matters more than ever Rochelle Ann Burgess, Richard H Osborne, Kenneth A Yongabi, Trisha Greenhalgh, Deepti Gurdasani, Gagandeep Kang, et al. (+6)
490 [GO] 2020―Dec―11 Is my cough COVID-19? Eric J Topol
491 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury Kay Weng Choy
492 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply Fabian Braun, Carolin Edler, Victor G Puelles, Tobias B Huber
493 [GO] 2020―Dec―11 The infective nurture of pandemic comics Ciléin Kearns, Dale Fisher, Yap Seng Chong
494 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? Courtney Waugh, Su Shiung Lam, Christian Sonne
495 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? - Authors' reply John H Amuasi, Andrea S Winkler
496 [GO] 2020―Dec―08 Oxford-AstraZeneca COVID-19 vaccine efficacy Maria Deloria Knoll, Chizoba Wonodi
497 [GO] 2020―Dec―08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+757)
498 [GO] 2020―Dec―04 Is NHS Test and Trace exacerbating COVID-19 inequalities? Adam D M Briggs, Caroline Fraser
499 [GO] 2020―Dec―03 An African plan to control COVID-19 is urgently needed The Lancet
500 [GO] 2020―Dec―03 South Africa and India push for COVID-19 patents ban Ann Danaiya Usher
501 [GO] 2020―Dec―03 Offline: COVID-19-what have we learned so far? Richard Horton
502 [GO] 2020―Dec―02 Climate and COVID-19: converging crises The Lancet
503 [GO] 2020―Dec―01 Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage Arush Lal, Ngozi A Erondu, David L Heymann, Githinji Gitahi, Robert Yates
504 [GO] 2020―Nov―30 Centring adolescent girls and young women in the HIV and COVID-19 responses Ameena Goga, Linda Gail Bekker, Philippe Van de Perre, Wafaa El-Sadr, Khatija Ahmed, Mookho Malahleha, et al. (+4)
505 [GO] 2020―Nov―26 Applying for residency in the time of COVID-19 Tema Fodje, Esther Choo
506 [GO] 2020―Nov―26 A tribute to some of the doctors who died from COVID-19 Andrew Green
507 [GO] 2020―Nov―26 Maintaining the HIV response in a world shaped by COVID-19 The Lancet
508 [GO] 2020―Nov―26 Afghanistan braced for second wave of COVID-19 Sophie Cousins
509 [GO] 2020―Nov―26 Offline: Europe and COVID-19-struggling with tragedy Richard Horton
510 [GO] 2020―Nov―24 Smart system of disease management for patient follow-up and medication refill during the COVID-19 epidemic period: a multicentre retrospective cohort study Lingli Dong, Anbin Huang, Shengtao Zhang, Yikai Yu, Shouxin li, Lingxun Shen, et al. (+4)
511 [GO] 2020―Nov―24 The attitude and psychological status of medical staff in China during the COVID-19 outbreak: a cross-sectional survey Ziyi Yan, Yali Cui, Wen Chen, Mingjing Yu, Qichen Long, Yunyi Yuan, et al. (+4)
512 [GO] 2020―Nov―20 Urgent actions and policies needed to address COVID-19 among UK ethnic minorities Rohini Mathur, Laura Bear, Kamlesh Khunti, Rosalind M Eggo
513 [GO] 2020―Nov―20 Tackling COVID-19 in the Eastern Mediterranean Region Ahmed Salim Al-Mandhari, Richard J Brennan, Abdinasir Abubakar, Rana Hajjeh
514 [GO] 2020―Nov―20 COVID-19 vaccines: no time for complacency The Lancet
515 [GO] 2020―Nov―20 Notice of addendum to Article reporting Oxford trial of ChAdOx1 nCoV-19 vaccine Andrew J Pollard
516 [GO] 2020―Nov―19 Age and frailty in COVID-19 vaccine development Melissa K Andrew, Janet E McElhaney
517 [GO] 2020―Nov&h